Trial: 202007217

A MULTI-CENTER, OPEN-LABEL, PHASE 2 STUDY TO EVALUATE SAFETY AND EFFICACY OF U3-1402 IN SUBJECTS WITH ADVANCED OR METASTATIC COLORECTAL CANCER (CRC)

Phase

II

Principal Investigator

Pedersen, Katrina

Disease Site

Colon; Rectum

Learn more about this study at: clinicaltrials.gov